Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by Tiltan Pharma Ltd..
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
Tzivia Berkman, Tiltan Pharma Ltd. Identifier:
First received: July 23, 2012
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)